Generation of Neutralizing Activity against Human Immunodeficiency Virus Type 1 in Serum by Antibody Gene Transfer

Although several human immunodeficiency virus (HIV) vaccine approaches have elicited meaningful antigen-specific T-cell responses in animal models, no single vaccine candidate has engendered antibodies that broadly neutralize primary isolates of HIV type 1 (HIV-1). Thus, there remains a significant...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Lewis, Anne D., Chen, Ruju, Montefiori, David C., Johnson, Philip R., Clark, K. Reed
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC136414/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12163597/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.17.8769-8775.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!